Legal Information and Resources

The Avandia news continues. Just last month, there was a meeting of a joint advisory committee reporting to the Food and Drug Administration (FDA) concerning the potential health risks of the diabetes drug Avandia. This was the second meeting of this committee. It originally met in July of 2007 and reported that Avandia was associated with an increased risk of heart attacks. Three years have now passed, and the committee has met again, and this time, although 12 members of the committee voted to withdraw Avandia from the marketplace, 21 members voted that it remain available for sale and use. (more…)

The hits just keep coming for drug giant J&J who recently issued recalls for some its most popular and profitable products like Children’s Tylenol, and just last week, its Acuvue contact lenses had to be pulled from the Asian and European markets. Yesterday, J&J’s DePuy Orthopedic division recalled the ASR XL Acetabular System, a hip socket used in traditional hip replacement, and the ASR Hip Resurfacing System, a partial hip replacement that involves placing a metal cap on the ball of the femur, a method intended to preserve more bone. (more…)